TMDX [NASD]
TransMedics Group, Inc.
Index- P/E- EPS (ttm)-1.71 Insider Own0.20% Shs Outstand27.98M Perf Week3.37%
Market Cap1.51B Forward P/E- EPS next Y-1.22 Insider Trans-78.42% Shs Float26.74M Perf Month42.51%
Income-47.70M PEG- EPS next Q-0.42 Inst Own72.00% Short Float5.90% Perf Quarter62.96%
Sales51.40M P/S29.37 EPS this Y-37.60% Inst Trans1.31% Short Ratio4.59 Perf Half Y217.12%
Book/sh1.82 P/B26.15 EPS next Y45.80% ROA-37.60% Target Price47.50 Perf Year63.80%
Cash/sh1.83 P/C25.99 EPS next 5Y- ROE-74.20% 52W Range10.00 - 49.27 Perf YTD148.43%
Dividend- P/FCF- EPS past 5Y-6.10% ROI-38.30% 52W High-3.39% Beta-
Dividend %- Quick Ratio3.40 Sales past 5Y37.30% Gross Margin72.30% 52W Low376.00% ATR3.09
Employees148 Current Ratio4.20 Sales Q/Q150.00% Oper. Margin-81.90% RSI (14)67.83 Volatility6.51% 8.00%
OptionableYes Debt/Eq0.70 EPS Q/Q-6.60% Profit Margin-92.80% Rel Volume0.79 Prev Close47.00
ShortableYes LT Debt/Eq0.70 EarningsAug 01 AMC Payout- Avg Volume343.89K Price47.60
Recom2.00 SMA2019.44% SMA5039.75% SMA20090.82% Volume271,474 Change1.28%
Aug-02-22Upgrade JP Morgan Neutral → Overweight $48
Oct-08-20Downgrade JP Morgan Overweight → Neutral $15
Apr-07-20Initiated Oppenheimer Outperform $25
May-28-19Initiated Morgan Stanley Equal-Weight
May-28-19Initiated JP Morgan Overweight
May-28-19Initiated Cowen Outperform
May-28-19Initiated Canaccord Genuity Buy
Aug-04-22 08:19PM  
Aug-03-22 04:36PM  
Aug-01-22 06:15PM  
04:05PM  
Jul-26-22 04:05PM  
Jul-18-22 04:05PM  
Jul-17-22 08:04AM  
Jul-14-22 10:45AM  
Jun-25-22 09:00AM  
Jun-24-22 06:14AM  
Jun-03-22 04:05PM  
May-30-22 08:20AM  
May-07-22 08:08AM  
May-04-22 11:17AM  
May-03-22 05:45PM  
04:05PM  
Apr-28-22 07:00AM  
Apr-21-22 04:05PM  
Apr-19-22 06:04PM  
04:05PM  
Apr-14-22 07:27AM  
Mar-21-22 07:30AM  
Mar-01-22 04:05PM  
Feb-28-22 04:26AM  
Feb-25-22 04:05PM  
Feb-23-22 06:05PM  
04:05PM  
Feb-22-22 04:05PM  
Feb-21-22 10:58AM  
Feb-09-22 04:05PM  
Feb-08-22 02:38PM  
Jan-19-22 09:38AM  
Jan-14-22 09:32AM  
Jan-05-22 06:41PM  
Dec-24-21 11:38PM  
Dec-22-21 07:00AM  
Dec-17-21 08:38PM  
Dec-01-21 05:09AM  
Nov-11-21 04:05PM  
Nov-09-21 06:15PM  
04:05PM  
Nov-04-21 04:05PM  
09:57AM  
07:00AM  
Nov-02-21 03:01PM  
Oct-26-21 04:05PM  
01:20PM  
Sep-29-21 07:00AM  
Sep-20-21 01:08PM  
Sep-10-21 04:59PM  
Sep-08-21 11:17AM  
Sep-07-21 11:11AM  
07:00AM  
Aug-26-21 04:05PM  
Aug-09-21 04:05PM  
Aug-05-21 08:35PM  
04:05PM  
08:24AM  
Jul-29-21 06:05PM  
03:05PM  
Jul-28-21 04:05PM  
Jul-22-21 04:05PM  
Jul-14-21 09:00PM  
07:30AM  
07:05AM  
Jun-14-21 11:35AM  
Jun-10-21 10:35AM  
Jun-08-21 04:05PM  
May-26-21 07:00AM  
May-04-21 06:35PM  
04:01PM  
02:30PM  
Apr-22-21 07:43AM  
Apr-20-21 04:05PM  
Apr-15-21 05:30AM  
Apr-09-21 07:41AM  
Apr-07-21 08:50AM  
Apr-06-21 10:20PM  
05:30PM  
07:05AM  
Mar-24-21 04:05PM  
Mar-12-21 06:01AM  
Mar-10-21 01:00PM  
Mar-04-21 12:29AM  
Mar-02-21 05:35PM  
04:38PM  
04:01PM  
02:30PM  
Mar-01-21 04:15PM  
Feb-16-21 04:05PM  
04:01PM  
Feb-05-21 08:44AM  
Dec-24-20 08:00AM  
Dec-23-20 04:01PM  
Dec-07-20 04:06PM  
Nov-04-20 08:31PM  
06:45PM  
04:01PM  
02:30PM  
Oct-29-20 04:02PM  
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hassanein Waleed HPresident & CEOAug 12Sale48.007,000336,000486,285Aug 15 05:50 PM
Hassanein Waleed HPresident & CEOAug 11Sale46.7412,929604,301493,285Aug 15 05:50 PM
Carey John FVP of OperationsAug 01Option Exercise2.213,0006,6303,771Aug 01 08:40 PM
Carey John FVP of OperationsAug 01Sale41.273,000123,802771Aug 01 08:40 PM
Khayal Tamer IChief Commercial OfficerJul 29Option Exercise1.4013,50418,88059,580Aug 01 08:30 PM
Carey John FVP of OperationsJul 29Option Exercise7.864,00031,4344,771Aug 01 08:40 PM
Carey John FVP of OperationsJul 29Sale40.014,000160,040771Aug 01 08:40 PM
Khayal Tamer IChief Commercial OfficerJul 29Sale40.0113,504540,29546,076Aug 01 08:30 PM
TOBIN JAMES RDirectorJul 29Sale39.9848,5151,939,630253,591Aug 01 08:30 PM
Carey John FVP of OperationsJul 20Option Exercise13.991,50020,9921,879Jul 22 05:00 PM
Carey John FVP of OperationsJul 20Sale34.571,50051,855379Jul 22 05:00 PM
Carey John FVP of OperationsJul 11Option Exercise16.141,50024,2101,879Jul 12 05:27 PM
Carey John FVP of OperationsJul 11Sale32.981,50049,470379Jul 12 05:27 PM
Khayal Tamer IChief Commercial OfficerJul 05Option Exercise0.2813,5043,78159,580Jul 06 06:17 PM
Gordon StephenChief Financial OfficerJul 05Option Exercise2.2110,00022,10015,714Jul 06 06:19 PM
Khayal Tamer IChief Commercial OfficerJul 05Sale35.0613,504473,45046,076Jul 06 06:17 PM
Gordon StephenChief Financial OfficerJul 05Sale35.0010,000350,0005,714Jul 06 06:19 PM
TOBIN JAMES RDirectorJul 05Sale35.0048,5151,698,025302,106Jul 06 06:17 PM
Carey John FVP of OperationsJun 28Option Exercise0.282,7247633,103Jun 29 06:05 PM
Carey John FVP of OperationsJun 28Sale32.872,72489,538379Jun 29 06:05 PM
Carey John FVP of OperationsJun 27Option Exercise0.283,3209303,699Jun 27 07:59 PM
Carey John FVP of OperationsJun 27Sale32.593,320108,199379Jun 27 07:59 PM
Carey John FVP of OperationsJun 24Option Exercise0.282,9568283,335Jun 27 07:59 PM
Carey John FVP of OperationsJun 24Sale32.572,95696,277379Jun 27 07:59 PM
Carey John FVP of OperationsJun 01Option Exercise0.281,5004201,879Jun 03 05:00 PM
Carey John FVP of OperationsJun 01Sale28.191,50042,279379Jun 03 05:00 PM
Carey John FVP of OperationsMay 04Option Exercise0.281,5004201,879May 06 04:05 PM
TOBIN JAMES RDirectorMay 04Sale29.9448,5161,452,569350,621May 06 04:05 PM
Carey John FVP of OperationsMay 04Sale25.311,50037,965379May 06 04:05 PM
Carey John FVP of OperationsApr 01Option Exercise0.281,5004201,879Apr 04 06:30 PM
Carey John FVP of OperationsApr 01Sale26.851,50040,275379Apr 04 06:30 PM
Carey John FVP of OperationsMar 28Option Exercise10.854,50048,8274,879Mar 30 07:19 PM
Carey John FVP of OperationsMar 28Sale25.014,500112,545379Mar 30 07:19 PM
Hassanein Waleed HPresident & CEOJan 06Option Exercise0.28122,37134,264526,214Jan 07 05:00 PM
Provost MiriamVP of US Regulatory & FDA Rel.Dec 23Option Exercise3.228842,8469,438Dec 28 04:30 PM
KANIA EDWIN M JRDirectorNov 29Buy22.56100,0002,256,215302,893Nov 30 04:15 PM
Carey John FVP of OperationsNov 01Option Exercise2.211,6803,7131,680Nov 02 05:45 PM
Carey John FVP of OperationsNov 01Sale28.161,68047,3090Nov 02 05:45 PM
Carey John FVP of OperationsOct 01Option Exercise2.211,6803,7131,680Oct 05 04:52 PM
Carey John FVP of OperationsOct 01Sale32.331,68054,3170Oct 05 04:52 PM
Provost MiriamVP of US Regulatory & FDA Rel.Sep 15Option Exercise16.145,62590,78812,431Sep 17 04:34 PM
Provost MiriamVP of US Regulatory & FDA Rel.Sep 15Sale31.343,877121,5058,554Sep 17 04:34 PM
Gordon StephenChief Financial OfficerSep 07Option Exercise0.6710,0006,70015,714Sep 09 06:14 PM
Khayal Tamer IChief Commercial OfficerSep 07Option Exercise0.283,9411,10350,017Sep 09 06:25 PM
Gordon StephenChief Financial OfficerSep 07Sale35.0010,000350,0005,714Sep 09 06:14 PM
Khayal Tamer IChief Commercial OfficerSep 07Sale35.083,941138,25046,076Sep 09 06:25 PM
Carey John FVP of OperationsSep 01Option Exercise2.211,6803,7131,680Sep 03 05:14 PM
Carey John FVP of OperationsSep 01Sale31.981,68053,7340Sep 03 05:14 PM
Sullivan John FVP of Quality & EngineeringAug 30Option Exercise0.283,20089614,273Sep 01 05:04 PM